Company ProfilePremium

Arbor Pharmaceuticals, LLC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Arbor Pharmaceuticals, LLC - Healthcare showcase

Year Founded & Workforce

2013

400 Employees

Industry

Healthcare

Services

Chemotherapy
A

Arbor Pharmaceuticals, LLC Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Arbor Pharmaceuticals, LLC Overview

Company Headquarters: Georgia, US

Founded: 2013

Workforce: ~400

Company Working: Arbor Pharmaceuticals, LLC (Arbor Pharmaceuticals) is a specialty pharmaceutical company based in the US that researches, develops, manufactures, and commercializes prescription products. The company operates through hospital & specialty, cardiology, neuroscience, pediatrics, and legacy & generics businesses. Gliadel is a registered trademark of Eisai Inc. and is manufactured by Eisai Inc., for Arbor Pharmaceuticals. The company markets various generic prescription products through its Wilshire division and has over a dozen abbreviated new drug applications (ANDAs) on file with the FDA and many others in different stages of development. The company produces novel chemical entities and previously approved molecules for new indications or in improved dosage forms.

Strategy

Arbor Pharmaceuticals focuses on collaborations with many of the local universities and discovery centers to identify innovations in the pharmaceuticals industry. Currently, the company is strongly emphasizing research & development (R&D) wherein; it has filed four new drug applications (NDAs), which have been approved by the FDA and has several additional products in late-stage development.

Company Snapshot

400

Employees

2013

Founded

Georgia, US

Headquarters

SWOT Analysis

Strengths

  • Robust R&D capabilities
  • Strong employee base

Weaknesses

  • Limited product portfolio
  • Insufficient geographical presence

Opportunities

  • Product portfolio expansion
  • Worldwide expansion

Threats

  • Increasing competition from other pharmaceutical companies
  • Price fluctuations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
–Product LaunchEisai Group launched Gliadel in Mexico for the treatment of patients with recurrent glioblastoma multiforme as an adjunct to surgery.

Product Offering

  • Arbor Pharmaceuticals, LLC
    • Chemotherapy

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.